180 Life Sciences Corp. financial data

Symbol
ATNF, ATNFW on Nasdaq
Industry
Pharmaceutical Preparations
Location
3000 El Camino Real, Bldg 4, Ste 200, Palo Alto, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
KBL MERGER CORP. IV (to 11/6/2020)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 58.8 % -19.9%
Debt-to-equity 163 % -12.1%
Return On Equity -212 % +63.8%
Return On Assets -80.7 % +60.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.19M shares +508%
Common Stock, Shares, Outstanding 3.18M shares +494%
Entity Public Float 1.55M USD -73.5%
Common Stock, Value, Issued 318 USD +489%
Weighted Average Number of Shares Outstanding, Basic 915K shares +141%
Weighted Average Number of Shares Outstanding, Diluted 915K shares +141%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.4M USD -39.2%
General and Administrative Expense 4.36M USD -59.1%
Operating Income (Loss) -6.32M USD +53.1%
Nonoperating Income (Expense) -139K USD +98.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -6.46M USD +71%
Income Tax Expense (Benefit) -2.35M USD
Net Income (Loss) Attributable to Parent -6.17M USD +69.1%
Earnings Per Share, Basic -15.5 USD/shares
Earnings Per Share, Diluted -15.5 USD/shares -30880%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 5.14M USD +41.3%
Intangible Assets, Net (Excluding Goodwill) 7.62M USD +371%
Goodwill 0 USD
Assets 12.8M USD +143%
Accounts Payable, Current 1.93M USD +2.14%
Accrued Liabilities, Current 740K USD -60.4%
Liabilities, Current 3.5M USD -30.8%
Deferred Income Tax Liabilities, Net 342K USD +22.8%
Liabilities 3.51M USD -34.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.92M USD -0.54%
Retained Earnings (Accumulated Deficit) -142M USD -11.1%
Stockholders' Equity Attributable to Parent 9.25M USD
Liabilities and Equity 12.8M USD +143%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.03M USD +73.3%
Net Cash Provided by (Used in) Financing Activities -264K USD +43.7%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 3.18M shares +494%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.3M USD +69.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.59M USD +132%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12.1K USD +66.2%
Deferred Tax Assets, Valuation Allowance 19.5M USD +4.65%
Deferred Tax Assets, Gross 20.7M USD +7.46%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -14.2M USD +28.8%
Deferred Income Tax Expense (Benefit) 2.3M USD
Deferred Tax Assets, Operating Loss Carryforwards 17.5M USD +6.44%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 154M USD +18.1%
Amortization of Intangible Assets 23.6K USD +8.29%
Share-based Payment Arrangement, Expense 16.5K USD -97.4%
Interest Expense 49.7K USD +326%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%